CCR10: Difference between revisions
CSV import |
CSV import |
||
| Line 25: | Line 25: | ||
[[Category:Human proteins]] | [[Category:Human proteins]] | ||
{{Receptor-stub}} | {{Receptor-stub}} | ||
{{No image}} | |||
Revision as of 08:54, 10 February 2025
CCR10 is a chemokine receptor that plays a significant role in the immune system. It is a member of the G protein-coupled receptor (GPCR) family and is primarily involved in the regulation of leukocyte trafficking. CCR10 is known to bind to the chemokines CCL27 and CCL28, which are crucial for the migration of T cells and other immune cells to specific tissues.
Structure
CCR10 is a seven-transmembrane receptor, characteristic of the GPCR family. It is encoded by the CCR10 gene located on chromosome 17 in humans. The receptor consists of an extracellular N-terminus, seven transmembrane helices, and an intracellular C-terminus.
Function
CCR10 is predominantly expressed in skin and mucosal tissues, where it mediates the homing of immune cells to these areas. The interaction between CCR10 and its ligands, CCL27 and CCL28, is essential for the immune surveillance and inflammatory responses in these tissues. This receptor-ligand interaction is particularly important in the context of skin diseases such as psoriasis and atopic dermatitis.
Ligands
- CCL27: Also known as cutaneous T-cell-attracting chemokine (CTACK), it is primarily expressed in the skin.
- CCL28: Also known as mucosa-associated epithelial chemokine (MEC), it is expressed in various mucosal tissues.
Clinical Significance
CCR10 and its ligands are implicated in several inflammatory diseases and autoimmune disorders. The receptor is a potential target for therapeutic interventions aimed at modulating immune cell trafficking to treat conditions such as psoriasis, atopic dermatitis, and other chronic inflammatory diseases.
Research
Ongoing research is focused on understanding the precise mechanisms by which CCR10 regulates immune cell migration and its role in various diseases. Studies are also exploring the potential of CCR10 as a therapeutic target for modulating immune responses in autoimmune diseases and cancer.
